# Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus

> **NCT01348217** · PHASE2,PHASE3 · COMPLETED · sponsor: **Centre Georges Francois Leclerc** · enrollment: 196 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **RADIATION:** Conformal 3D Radiotherapy with " ENI "-type prophylactic irradiation of the lymph node
- **RADIATION:** Boost
- **RADIATION:** Boost
- **DRUG:** chemotherapy: FOLFOX 4

## Key facts

- **NCT ID:** NCT01348217
- **Lead sponsor:** Centre Georges Francois Leclerc
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-06
- **Primary completion:** 2011-06-07
- **Final completion:** 2018-12-17
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2020-01-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01348217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01348217, "Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01348217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*